into the biochemical and metabolic status in the tissue, and often precedes anatomic changes seen on conventional T1-or T2-weighted images. In a normal full-term neonate without brain injury, there are robust N-acetyl aspartate (NAA), choline, and creatine peaks visible on MRS but no evidence of a lactate peak. NAA is present in high concentrations in the central nervous system (CNS) and is a marker of the functional integrity of neuronal mitochondrial metabolism. 9 It is reduced in most neurodegenerative processes and neuronal and axonal injury. Choline is a precursor for membrane synthesis in the CNS and reflects the structural components of the membrane myelin sheaths. 10 Choline peaks increase with increased cellular and myelin sheath injury. The creatine peak consists of the creatine and phosphocreatine protons and remains relatively stable, making it a useful standard for comparison with other metabolic peaks. In contrast, in HIE, brain lactate measured in the deep gray matter, specifically in the thalamus, is elevated, reflecting anaerobic glycolysis. 11, 12 Brain lactate measured by MRS is an established biomarker of long-term neurologic morbidity in infants born preterm and those with HIE. 13, 14 However, no data exist regarding the relationship between brain lactate and cord blood lactate in infants in term-born infants not selected by HIE. We aimed to use MRS techniques to detect and quantify cerebral lactate shortly after birth and to correlate brain lactate with umbilical artery lactate in anatomically normal term infants.
Materials and Methods
We performed a nested case-control study within a prospective cohort study of more than 8,000 consecutive term (! 37 weeks) births. Women with singleton, nonanomalous pregnancies admitted for delivery were included in the parent cohort, which is aimed at identifying patterns of electronic fetal monitoring (EFM) and intrapartum factors predictive of term birth morbidity. Additional inclusion criteria were the continuous use of EFM in labor and umbilical artery lactate obtained at birth, both of which are universal at our institution. Lactate is part of the routine analysis performed on all umbilical artery pH samples. For umbilical artery cord samples, a clamped segment of cord immediately after delivery was obtained. To measure umbilical artery pH and umbilical artery lactate, whole blood was placed in automated benchtop analyzers. Specifically, the GEM Premier 4000 analyzer (Bedford, MA) was used to measure umbilical artery pH and the DXC-800 automated chemistry analyzer (Brea, CA) was used for the umbilical artery lactate assays. Informed consent was obtained from all participants.
Cases were identified as the first 55 infants born with an umbilical artery pH 7.10. Three controls (with an umbilical artery pH > 7.20) were chosen for every case using a random number generator based on study identification number in the parent cohort, then matched by gender and race to be representative of the cohort population. The neonatal participants underwent nonsedated cerebral MRI in the first 72 hours of life on a Siemens 3T Tim Trio scanner. After T1 and T2 sequences were acquired, research sequences including MRS were . Spectroscopy data were analyzed using algorithms provide by the Siemen's spectroscopy tab at the scanner console, as previously used in prior studies in humans and animals. 15 Blind to umbilical artery lactate and clinical data, a single technician placed a region of interest (ROI) over the left thalamus where MRS data were obtained to measure brain lactate. The thalamus is the accepted neuroimaging standard ROI when evaluating MRS in the setting of HIE. 11 The basal ganglia are affected more severely in HIE because they have higher energy demands and more developed neurotransmission compared with the cortical gray matter. Quantitation of metabolites was done by measuring the integral values of each metabolite. The integral value of the metabolite is proportional to the tissue concentrations; therefore, the ratios of the integral values are proportional to the ratios of the concentrations. 16 The lactate peak, completely inverted at a TE of 144 ms, was identified as a doublet at 1.33 ppm resonance frequency. As is standard, NAA and choline were measured and used for normalization (►Fig. 1).
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Descriptive analyses were used to describe the participants overall and by presence or absence of brain lactate with the use of Fisher exact test, two-sample Student t-test, or Wilcoxon rank-sum test. Stratified analyses identified potentially confounding factors, and linear regressions were used to estimate the relationship between umbilical artery lactate and brain lactate. The final models adjusted for the remaining significant variables, day of life at delivery was not retained, but mode of delivery, nulliparity, and fever remained and the models were tested with the Hosmer-Lemeshow goodness- 
Results
In this study, 220 infants underwent MRI. Of those, 20 underwent MRI before the lactate sequencing was added to the protocol, an additional 22 had no spectral sequence performed due to intolerance of length of exam and three more had MRI studies with quality insufficient for MRS interpretation, leaving 175 infants available for analysis. Fifty-two infants had an inverted lactate doublet peak qualitatively identified on the single voxel in the left thalamus. Selected clinical characteristics assessed based on the presence or absence of brain lactate peak demonstrated no significant difference in average maternal age, parity, or body mass index, although the majority of the women were obese (►Table 1). Infants with a visible brain lactate peak on the MRI studies were more likely to deliver vaginally, either spontaneously or by operative vaginal delivery. Importantly for this analysis, case or control status did not differ between the groups (p ¼ 0.93).
Of the infants with a brain lactate peak, umbilical artery lactate values ranged from 1.6 to 11.4 mmol/L, and correlated with a rise in brain lactate (►Fig. 2). After adjusting for mode of delivery, fever, and nulliparity, increasing umbilical artery lactate was significantly associated with an increase in quantitative brain lactate. These results were replicated with a significant association between umbilical artery gas and the lactate to NAA ratios. For every 1 mmol/L increase in umbilical artery lactate, we found an increase in quantitative brain lactate of 0.02 (►Table 2). We also found that often proposed surrogate markers for morbidity in term-born infants, such as Apgar scores, 1 umbilical artery pH, and level of nursery admission did not distinguish infants with brain lactate peaks from those without. More than 95% of the infants with a brain lactate peak on MRS were admitted to the normal nursery without encephalopathy, and none was admitted to the NICU (►Table 3).
Discussion
We found that MRS measured brain lactate is significantly correlated with umbilical artery lactate in nonanomalous term infants, which may help explain the observed association between umbilical artery lactate and neurologic the measurement of umbilical artery lactate was found to be a superior predictor of neonatal morbidity in comparison to umbilical artery pH or base excess in term infants. The authors performed detailed analyses that suggested umbilical artery lactate provided greater sensitivity and specificity compared with pH (83.9 and 74.1% compared with 75.0 and 70.6%). 21 The use of umbilical artery lactate is a significant surrogate marker because of its ability to directly measure anaerobic metabolism, which has a stronger biological basis than either umbilical artery pH or base excess level due to the varying methods by which pH and base excess are calculated and estimated.
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There are potential limitations of our study to consider. Due to its observational nature, the potential for confounding is present. However, multivariable analyses allowed us to adjust for potential confounders in our estimates of the relationship between lactate in the umbilical artery and the brain. There is also an inherent component of subjectivity in certain components of advanced MRI techniques, such as MRS. We attempted to minimize these by having a single, experienced MR analyst conducts the MRS analysis in standard fashion blind to all clinical data including umbilical cord blood parameters. Finally, while umbilical artery lactate and brain lactate were significantly associated, correlation was weak in our study.
We would like to offer some strengths to consider as well. First, this is a large study that included not just acidotic infants undergoing cerebral MRI shortly after birth, but nonacidotic, otherwise normal, full-term neonates as well. The random sampling of the controls and nesting of this study within an unselected larger cohort allows generalizability and reduces selection bias. Robust clinical data allowed us to plan for and measure relevant potentially confounding factors.
In conclusion, we found that in nonanomalous term infants, umbilical artery lactate is significantly correlated with the amount of brain lactate detected by MRS. We also noted that the majority of infants in our cohort with elevated cord and brain lactate were clinically normal and that, contrary to reports in the literature, these metabolic abnormalities are transiently present in a subset of transitioning normal newborns. Thus, the presence of elevated brain lactate may be necessary but not sufficient to detect brain injury in neonatal HIE. This finding may begin to explain why recent observational data have demonstrated an association between umbilical artery lactate and morbidities in term-born infants, and described it to be a superior marker compared with others. 21 These findings represent one step within the overarching aims of this study to explore the use of neonatal MRI to identify term-born infants at risk to allow intervention. Additional advanced analyses will allow us to explore the use of MRS lactate in combination with other MRI findings both in correlation to risk of injury as well as to potentially explain, in part, the relationship between umbilical artery lactate and term infant morbidity. However, we believe this was an important first step in pursuit of biomarkers for the majority of neurologic injuries at term.
Note
This study was presented orally as an abstract at the 34th annual meeting of the Society of Maternal and Fetal Medicine, New Orleans, LA, February 3-8, 2014.
